MX346904B - Sistema para la activacion de un liquido. - Google Patents

Sistema para la activacion de un liquido.

Info

Publication number
MX346904B
MX346904B MX2014007340A MX2014007340A MX346904B MX 346904 B MX346904 B MX 346904B MX 2014007340 A MX2014007340 A MX 2014007340A MX 2014007340 A MX2014007340 A MX 2014007340A MX 346904 B MX346904 B MX 346904B
Authority
MX
Mexico
Prior art keywords
liquid
base
sparingly soluble
activation system
soluble acid
Prior art date
Application number
MX2014007340A
Other languages
English (en)
Other versions
MX2014007340A (es
Inventor
Xu Guofeng
Miller Steven
Gronlund Jennifer
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of MX2014007340A publication Critical patent/MX2014007340A/es
Publication of MX346904B publication Critical patent/MX346904B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/0283—Matrix particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/88—Polyamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Mathematical Physics (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cosmetics (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describen composiciones que comprenden un líquido inactivado, un ácido o base escasamente soluble inmovilizada, de manera que durante el almacenamiento el líquido inactivo no está en contacto con el ácido o base escasamente soluble inmovilizada, pero ante el uso, el líquido inactivo se pone en contacto con el ácido o base escasamente soluble inmovilizada, mediante lo cual se altera el pH del líquido y en consecuencia se activa el líquido para proveer un beneficio; junto con variantes y diseños alternativos, métodos para elaborar y usar las composiciones, y componentes de las mismas.
MX2014007340A 2011-12-19 2012-12-19 Sistema para la activacion de un liquido. MX346904B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161577555P 2011-12-19 2011-12-19
PCT/US2012/070572 WO2013096425A2 (en) 2011-12-19 2012-12-19 Liquid activation system

Publications (2)

Publication Number Publication Date
MX2014007340A MX2014007340A (es) 2014-09-15
MX346904B true MX346904B (es) 2017-04-05

Family

ID=47501528

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014007340A MX346904B (es) 2011-12-19 2012-12-19 Sistema para la activacion de un liquido.

Country Status (16)

Country Link
US (1) US10238590B2 (es)
EP (1) EP2790791B1 (es)
JP (1) JP2015500348A (es)
CN (1) CN104394937B (es)
AR (1) AR089312A1 (es)
AU (1) AU2012359083B2 (es)
BR (1) BR112014014811A2 (es)
CA (1) CA2858257A1 (es)
CO (1) CO6990715A2 (es)
HK (1) HK1201773A1 (es)
MX (1) MX346904B (es)
PH (1) PH12014501307A1 (es)
RU (1) RU2014129870A (es)
SG (1) SG11201402538SA (es)
TW (1) TW201338791A (es)
WO (1) WO2013096425A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014067933A1 (en) * 2012-10-31 2014-05-08 C-Lecta Gmbh Bioactive carrier preparation for enhanced safety in care products and food
EP3383357B1 (en) * 2015-12-17 2021-07-21 Colgate-Palmolive Company Hydrogen peroxide booster system for enhanced teeth whitening
JP7127524B2 (ja) * 2018-12-18 2022-08-30 ライオン株式会社 口腔用製品

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3678154A (en) 1968-07-01 1972-07-18 Procter & Gamble Oral compositions for calculus retardation
US3535421A (en) 1968-07-11 1970-10-20 Procter & Gamble Oral compositions for calculus retardation
US4041149A (en) * 1976-01-12 1977-08-09 Colgate-Palmolive Company Composition and method of controlling and preventing mouth odor
US4885155A (en) 1982-06-22 1989-12-05 The Procter & Gamble Company Anticalculus compositions using pyrophosphate salt
US5288480A (en) 1987-01-30 1994-02-22 Colgate-Palmolive Co. Antiplaque antibacterial oral composition
US4905825A (en) 1989-07-20 1990-03-06 Brader Allen C Container having lid activated mixing mechanism
US5302373A (en) * 1993-06-10 1994-04-12 Church & Dwight Co., Inc. Liquid mouthwash containing a particulate bicarbonate suspension
CA2300676A1 (en) 1997-09-02 1999-03-11 Unilever Plc Oral compositions
JP2004500404A (ja) * 2000-03-27 2004-01-08 カール　−　ツァイス　−　シュティフツング 生物活性ガラスを含む新規化粧品、ボディケア、洗浄剤および栄養サプリメント組成物および製造方法およびその使用
GB2365018A (en) * 2000-07-24 2002-02-13 Procter & Gamble Water soluble pouches
DE10122380A1 (de) 2001-05-09 2002-11-28 Schuelke & Mayr Gmbh Alkoholfreies Flüssig-Konzentrat zur Konservierung von kosmetischen, Haushalts- und technischen Produkten
US7053034B2 (en) 2002-04-10 2006-05-30 Salvona, Llc Targeted controlled delivery compositions activated by changes in pH or salt concentration
US20040062723A1 (en) 2002-09-27 2004-04-01 Zaidel Lynette A. Dual component tooth whitening dentifrice
MXPA05004690A (es) 2002-11-02 2005-08-26 Venture Man Alliance Llc Componentes acuosos activados transportados en un sistema de vehiculo no acuoso.
US7601002B2 (en) 2004-03-29 2009-10-13 Colgate-Palmolive Co Dental whitening method
US20050210615A1 (en) 2004-03-29 2005-09-29 Ramachandra Shastry Oral care method
US20060024246A1 (en) * 2004-07-29 2006-02-02 Prithwiraj Maitra Oral care compositions with film forming polymers
US9271902B2 (en) * 2005-02-15 2016-03-01 Martin S. Giniger Whitening system capable of delivering effective whitening action
US9289362B2 (en) * 2005-02-15 2016-03-22 Martin S. Giniger Foaming compositions and methods
WO2007111630A1 (en) 2005-07-29 2007-10-04 Flexitral, Inc. Compounds which release an odor on a change in ph
HUP0600765A2 (en) * 2006-10-06 2008-10-28 Istvan Piller Container for stable carbondioxide foam, process for producing stable carbondioxide foam and method for using of foam
RU2471475C2 (ru) 2008-02-08 2013-01-10 Колгейт-Палмолив Компани Продукт для ухода за полостью рта и способы его применения и получения
US20120283668A1 (en) 2011-05-04 2012-11-08 Pinchas Shalev Apparatus and method for using effervescent tablets for cosmetic care

Also Published As

Publication number Publication date
HK1201773A1 (en) 2015-09-11
CO6990715A2 (es) 2014-07-10
CN104394937A (zh) 2015-03-04
WO2013096425A3 (en) 2014-03-27
CN104394937B (zh) 2017-09-22
EP2790791B1 (en) 2017-04-19
MX2014007340A (es) 2014-09-15
CA2858257A1 (en) 2013-06-27
US10238590B2 (en) 2019-03-26
EP2790791A2 (en) 2014-10-22
BR112014014811A2 (pt) 2017-06-13
AU2012359083A1 (en) 2014-06-19
TW201338791A (zh) 2013-10-01
WO2013096425A2 (en) 2013-06-27
JP2015500348A (ja) 2015-01-05
AU2012359083B2 (en) 2015-11-26
PH12014501307A1 (en) 2014-09-15
SG11201402538SA (en) 2014-10-30
RU2014129870A (ru) 2016-02-10
AR089312A1 (es) 2014-08-13
US20150086487A1 (en) 2015-03-26

Similar Documents

Publication Publication Date Title
MX352823B (es) Formulaciones de proteinas que contienen aminoacidos.
TN2012000543A1 (en) Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
PH12015500561A1 (en) Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
NZ717728A (en) Stable formulations of a hyaluronan-degrading enzyme
EA201591474A1 (ru) Модуляторы метил-модифицирующих ферментов, композиции и их применение
CL2017000498A1 (es) Una formulación de n-acetilgalactosamina-6-sulfatasa humana activa altamente fosforida (galns)(divisional solicitud 219-2013)
PE20191815A1 (es) Formulaciones acuosas estables de adalimumab
UA118248C2 (uk) Інгібітори глюкозилцерамідсинтази
BR112014031424A2 (pt) tratamento de células pluripotentes
MX341955B (es) Articulos retrorreflectantes que incluyen areas opticamente activas y areas opticamente inactivas.
MX341957B (es) Articulos retrorreflectantes que incluyen areas opticamente activas y areas opticamente inactivas.
CL2008003910A1 (es) Formulacion liquida, estable, conteniendo anticuerpo que comprende arginina y metionina; procedimiento para inhibir la deamidacion de moleculas de un anticuerpo que comprende agregar arginina a la formulacion liquida.
MX2012012023A (es) Articulos retrorreflectantes que incluyen areas opticamente activas y areas opticamente inactivas.
BR112016001778A2 (pt) Célula transgênica de levedura, composição, e, métodos de produção de 3-hp e de produção de ácido acrílico ou um sal do mesmo
AR082943A1 (es) Formula nutricional predigerida
MX2012003296A (es) Gotas oculares acuosas que contienen latanoprost, y metodo para inhibir la adsorcion de latanoprost a una resina.
MX2016001006A (es) Policonjugados para suministro de desencadenantes de acido ribonucleico de interferencia (arni) en celulas tumorales en vivo.
MX2014016121A (es) Agente para prevenir el deterioro de la funcion endotelial vascular o para mejorar la funcion endotelial vascular.
WO2014124307A3 (en) Targeted theranostics
AU340528S (en) Insole
UA113188C2 (xx) Спосіб одержання гідрогелю з використанням ферментів ліпаз
PH12014501307A1 (en) Liquid activation system
TR201009167A2 (tr) Sefalosporin içeren farmasötik granüller.
RS53408B (en) PHARMACEUTICAL COMPOSITION OF IBUPROFEN FOR INJECTION
IN2014DN04600A (es)

Legal Events

Date Code Title Description
FG Grant or registration